{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:47:54Z","timestamp":1784742474425,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T00:00:00Z","timestamp":1659916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006383","name":"Cancer Society of Finland","doi-asserted-by":"publisher","award":["190101"],"award-info":[{"award-number":["190101"]}],"id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.ygyno.2022.07.023","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T01:28:43Z","timestamp":1660181323000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Alternative cytology triage strategies for primary HPV screening"],"prefix":"10.1016","volume":"167","author":[{"given":"Maija","family":"Vahteristo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Hein\u00e4vaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahti","family":"Anttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tytti","family":"Sarkeala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2022.07.023_bb0005","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0010","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0015","first-page":"F55","article-title":"Papillomavirus infections \u2014 a major cause of human cancers","volume":"1288","author":"Hausen","year":"1996","journal-title":"Biochim. Biophys. Acta BBA - Rev. Cancer."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0020","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.cmi.2019.09.006","article-title":"Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans","volume":"26","author":"Maver","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: the transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1471-0528.2004.00210.x","article-title":"Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer","volume":"111","author":"Nieminen","year":"2004","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(09)70360-2","article-title":"Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial","volume":"11","author":"Ronco","year":"2010","journal-title":"Lancet Oncol."},{"issue":"1\u2013150","key":"10.1016\/j.ygyno.2022.07.023_bb0040","first-page":"iii","article-title":"ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening","volume":"13","author":"Kitchener","year":"2009","journal-title":"Health Technol. Assess. Winch. Engl."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0045","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMoa073204","article-title":"Human papillomavirus and Papanicolaou tests to screen for cervical cancer","volume":"357","author":"Naucler","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0050","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1470-2045(11)70296-0","article-title":"Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial","volume":"13","author":"Rijkaart","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1754","article-title":"Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study","volume":"337","author":"Dillner","year":"2008","journal-title":"BMJ."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bpobgyn.2017.08.012","article-title":"Secondary prevention of cervical cancer","volume":"47","author":"Basu","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0065","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1007\/BF03405681","article-title":"Self-collected HPV testing improves participation in cervical cancer screening: a systematic review and meta-analysis","volume":"104","author":"Racey","year":"2013","journal-title":"Can. J. Public Health."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0070","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12916-019-1460-0","article-title":"Introduction of primary screening using high-risk HPV DNA detection in the Dutch cervical cancer screening programme: a population-based cohort study","volume":"17","author":"Aitken","year":"2019","journal-title":"BMC Med."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0075","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ijc.33519","article-title":"Human papillomavirus load and genotype analysis improves the prediction of invasive cervical cancer","volume":"149","author":"Hortlund","year":"2021","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1471-0528.2009.02263.x","article-title":"After-effects reported by women following colposcopy, cervical biopsies and LLETZ: results from the TOMBOLA trial","volume":"116","author":"The TOMBOLA (Trial Of Management of Borderline and Other Low-grade Abnormal smears) Group","year":"2009","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0085","series-title":"European guidelines for quality assurance in cervical cancer screening: second edition : supplements","author":"von Karsa","year":"2015"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0090","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2458-6-252","article-title":"Alternative technologies in cervical cancer screening: a randomised evaluation trial","volume":"6","author":"Anttila","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0095","doi-asserted-by":"crossref","first-page":"e7789","DOI":"10.1136\/bmj.e7789","article-title":"Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in Finland","volume":"345","author":"Leinonen","year":"2012","journal-title":"BMJ."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0100","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ejca.2007.12.002","article-title":"Screening with a primary human papillomavirus test does not increase detection of cervical cancer and intraepithelial neoplasia 3","volume":"44","author":"Kotaniemi-Talonen","year":"2008","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0105","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjc.6602799","article-title":"Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting","volume":"93","author":"Kotaniemi-Talonen","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0110","article-title":"Primary cervical screening with high risk human papillomavirus testing: observational study","volume":"364","author":"Rebolj","year":"2019","journal-title":"BMJ."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejca.2016.09.008","article-title":"Impact of variations in triage cytology interpretation on human papillomavirus\u2013based cervical screening and implications for screening algorithms","volume":"68","author":"Ronco","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0120","unstructured":"HPV Test: Effective in the Prevention of Cervical Cancer, (2022). https:\/\/www.kreftregisteret.no\/en\/General\/News\/HPV-test-Effective-in-the-prevention-of-cervical-cancer\/ (accessed January 10, 2022)."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0125","author":"Suomalaisen L\u00e4\u00e4k\u00e4riseuran Duodecimin ja Suomen Kolposkopiayhdistyksen Asettama Ty\u00f6ryhm\u00e4, Kohdunkaulan, em\u00e4ttimen ja Ulkosynnytinten Solumuutokset"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0130","author":"Stevenson"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0135","first-page":"119","article-title":"Approximate is better than \u201cExact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am. Stat."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0140","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003460","article-title":"Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme","volume":"4","author":"Nyg\u00e5rd","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1365-2303.2011.00849.x","article-title":"Large performance variation does not affect outcome in the Finnish cervical cancer screening programme: performance and outcome in cervical cancer screening","volume":"23","author":"L\u00f6nnberg","year":"2012","journal-title":"Cytopathology."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0150","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1158\/1055-9965.EPI-09-1038","article-title":"Low proportion of false-negative smears in the finnish program for cervical cancer screening","volume":"19","author":"L\u00f6nnberg","year":"2010","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/jnci\/djn444","article-title":"Efficacy of HPV DNA testing with cytology triage and\/or repeat HPV DNA testing in primary cervical cancer screening","volume":"101","author":"Naucler","year":"2009","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/1055-9965.EPI-13-0173","article-title":"Primary hrHPV DNA testing in cervical cancer screening: How to manage screen-positive women? A POBASCAM trial substudy","volume":"23","author":"Dijkstra","year":"2014","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0165","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJM198806303182605","article-title":"An assessment of clinically useful measures of the consequences of treatment","volume":"318","author":"Laupacis","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0170","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/ijc.25677","article-title":"Cervical cancer patterns with automation-assisted and conventional cytological screening: a randomized study","volume":"128","author":"Anttila","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0175","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jcv.2015.11.015","article-title":"Triage of HPV positive women in cervical cancer screening","volume":"76","author":"Wentzensen","year":"2016","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0180","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/ijc.28646","article-title":"Divergent coverage, frequency and costs of organised and opportunistic Pap testing in Finland","volume":"135","author":"Salo","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0185","first-page":"2004","article-title":"Ilmoitus rintasy\u00f6v\u00e4n ja kohdunkaulansy\u00f6v\u00e4n joukkotarkastuksista","volume":"6","author":"Stakes","year":"2004","journal-title":"Ohjeita ja Luokituksia"},{"key":"10.1016\/j.ygyno.2022.07.023_bb0190","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/jnci\/djp367","article-title":"Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting","volume":"101","author":"Leinonen","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0195","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1128\/JCM.00049-06","article-title":"Comparison of the Digene HC2 assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for detection of high-risk HPV genotypes in cervical samples","volume":"44","author":"Sandri","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.ygyno.2022.07.023_bb0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1128\/JCM.05400-11","article-title":"Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium","volume":"50","author":"Wong","year":"2012","journal-title":"J. Clin. Microbiol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822004954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825822004954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:02:28Z","timestamp":1758772948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825822004954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0090825822004954"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.07.023","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative cytology triage strategies for primary HPV screening","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2022.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}